Expression of the Epstein-Barr virus genome in a nasopharyngeal carcinoma epithelial tumor cell line

Int J Cancer. 1990 Nov 15;46(5):944-9. doi: 10.1002/ijc.2910460532.

Abstract

An epithelial tumor cell line was recently established from a biopsy specimen of a nasopharyngeal carcinoma (NPC), and designated HONE-I. Uncloned (parental) HONE-I and HONE-I clone (C)-40 cells were found to contain latent Epstein-Barr virus (EBV). Expression of the latent EBV genome in HONE-I C-40 cells has been examined. It was possible to detect a small percentage of cells spontaneously synthesizing EBV early antigen (EA) and virus capsid antigen (VCA) by immunofluorescence (IF). In addition, the EBV nuclear antigens (EBNA-I and EBNA-2), as well as the EBV latent membrane protein (LMP) were detected in the HONE-I cells. Attempts were made to induce the latent EBV genome in these cells with iododeoxyuridine (IUdR). We observed a significant increase in the number of EA/VCA-positive cells, an increase in EBV DNA, the synthesis of virus particles, and the rescue of infectious virus after treatment of HONE-I C-40 cells with IUdR. The HONE-I C-40 cells should facilitate studies of the expression and regulation of the EBV genome in NPC epithelial tumor cells, which have not previously been available.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, Viral / immunology
  • Antigens, Viral / physiology
  • Capsid Proteins*
  • DNA, Viral / biosynthesis
  • DNA, Viral / metabolism
  • Gene Expression
  • Genes, Viral / genetics*
  • Genomic Library
  • Herpesvirus 4, Human / genetics*
  • Herpesvirus 4, Human / immunology
  • Herpesvirus 4, Human / physiology
  • Humans
  • Idoxuridine / pharmacology
  • Nasopharyngeal Neoplasms / genetics*
  • Nasopharyngeal Neoplasms / microbiology
  • Tumor Virus Infections / genetics
  • Virus Replication / drug effects

Substances

  • Antigens, Viral
  • Capsid Proteins
  • DNA, Viral
  • Epstein-Barr viral capsid antigen
  • Epstein-Barr virus early antigen
  • Idoxuridine